Telomerase activation: A potential key modulator for human healthspan and longevity

Ageing Research Reviews

Volumn 15, Issue 1, 2014, Pages 1-5

  Boccardi, Virginia ^a   Paolisso, Giuseppe ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Ageing; Healthspan; Longevity; Telomerase; Telomeres

Indexed keywords

TELOMERASE;

AGING; CELL AGING; ENZYME ACTIVATION; HEALTH STATUS; HUMAN; LONGEVITY; MOLECULAR DYNAMICS; NONHUMAN; REVIEW; SENESCENCE; TELOMERE SHORTENING; AGED; PHYSIOLOGY; TELOMERE;

AGED; CELL AGING; ENZYME ACTIVATION; HUMANS; LONGEVITY; TELOMERASE; TELOMERE; TELOMERE SHORTENING;

EID: 84896029025     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2013.12.006     Document Type: Review

References (63)

1. Armanios M. Telomeres and age-related disease: how telomere biology informs clinical paradigms. J. Clin. Invest. 2013, 123(3):996-1002.
2. Armanios M., Alder J.K., Parry E.M., Karim B., Strong M.A., Greider C.W. Short telomeres are sufficient to cause the degenerative defects associated with aging. Am. J. Hum. Genet. 2009, 85:823-832.
3. Baker D.J., Wijshake T., Tchkonia T., LeBrasseur N.K., Childs B.G., van de Sluis B., Kirkland J.L., van Deursen J.M. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011, 479(7372):232-236.
4. Bayne S., Liu J.P. Hormones and growth factors regulate telomerase activity in ageing and cancer. Mol. Cell. Endocrinol. 2005, 240(1-2):11-22.
5. Blackburn E.H. Telomere states and cell fates. Nature 2000, 408(6808):53-56.
6. Blackburn E.H. Switching and signaling at the telomere. Cell 2001, 106:661-673.
7. Blasco M.A. Telomeres in cancer and aging: lessons from the mouse. Cancer Lett. 2003, 194:183-188.
8. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 2005, 6:611-622.
9. Boccardi V., Esposito A., Rizzo M.R., Marfella R., Barbieri M., Paolisso G. Mediterranean diet, telomere maintenance and health status among elderly. PLoS One 2013, 8(4):e62781.
10. Boccardi V., Barbieri M., Rizzo M.R., Marfella R., Esposito A., Marano L., Paolisso G. A new pleiotropic effect of statins in elderly: modulation of telomerase activity. FASEB J. 2013, 27(9):3879-3885.
11. Boccardi V., Herbig U. Telomerase gene therapy: a novel approach to combat aging. EMBO Mol. Med. 2012, 4(8):685-687.
12. Brown-Borg H.M., Bartke A. GH and IGF1: roles in energy metabolism of long-living GH mutant mice. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67:652-660.
13. Campisi J., d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 2007, 8:729-740.
14. Campisi J., Kim S.H., Lim C.S., Rubio M. Cellular senescence, cancer and aging: the telomere connection. Exp. Gerontol. 2001, 36(10):1619-1637.
15. Cawthon R.M., Smith K.R., O'Brien E., Sivatchenko Kerber A.R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003, 361:393-395.
16. Chiu C.P., Dragowska W., Kim N.W., Vaziri H., Yui J., Thomas T.E., Harley C.B., Lansdorp P.M. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 1996, 14(2):239-248.
17. Collado M., Blasco M.A., Serrano M. Cellular senescence in cancer and aging. Cell 2007, 130(2):223-233.
18. Daubenmier J., Lin J., Blackburn E., Hecht F.M., Kristeller J., Maninger N., Kuwata M., Bacchetti P., Havel P.J., Epel E. Changes in stress, eating, and metabolic factors are related to changes in telomerase activity in a randomized mindfulness intervention pilot study. Psychoneuroendocrinology 2012, 37:917-928.
19. de Jesus B.B., Schneeberger K., Vera E., Tejera A., Harley C.B., Blasco M.A. The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence. Aging Cell 2011, 10:604-621.
20. de Jesus B.B., Vera E., Schneeberger K., Tejera A.M., Ayuso E., Bosch F., Blasco M.A. Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol. Med. 2012, 4:1-14.
21. de Lange T. Protection of mammalian telomeres. Oncogene 2002, 21:532-540.
22. Eitan E., Tichon A., Gazit A., Gitler D., Slavin S., Priel E. Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis. EMBO Mol. Med. 2012, 4:313-329.
23. Epel E.S., Merkin S.S., Cawthon R., Blackburn E.H., Adler N.E., Pletcher M.J., Seeman T.E. The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men. Aging (Albany NY) 2009, 1:81-88.
24. Fauce S.R., Jamieson B.D., Chin A.C., Mitsuyasu R.T., Parish S.T., Ng H.L., Kitchen C.M., Yang O.O., Harley C.B., Effros R.B. Telomerase based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes. J. Immunol. 2008, 181:7400-7406.
25. Feng J., Funk W.D., Wang S.S., Weinrich S.L., Avilion A.A., Chiu C.P., Adams R.R., Chang E., Allsopp R.C., Yu J., Le S., West M.D., Harley C.B., Andrews W.H., Greider C.W., Villeponteau B. The RNA component of human telomerase. Science 1995, 269:1236-1241.
26. Fyhrquist F., Saijonmaa O. Telomere length and cardiovascular aging. Ann. Med. 2012, 44(1):S138-S142.
27. Garcia C.K., Wright W.E., Shay J.W. Human diseases of telomerase dysfunction: insights into tissue aging. Nucleic Acids Res. 2007, 35(22):7406-7416.
28. Gomes N.M., Ryder O.A., Houck M.L., Charter S.J., Walker W., Forsyth N.R., Austad S.N., Venditti C., Pagel M., Shay J.W., Wright W.E. Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination. Aging Cell 2011, 10:761-768.
29. Gonzalez-Suarez E., Geserick C., Flores J.M., Blasco M.A. Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice. Oncogene 2005, 24:2256-2270.
30. Hao L.Y., Armanios M., Strong M.A., Karim B., Feldser D.M., Huso D., Greider C.W. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 2005, 123:1121-1131.
31. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
32. Harley C.B., Liu W., Blasco M., Vera E., Andrews W.H., Briggs L.A., Raffaele J.M. A natural product telomerase activator as part of a health maintenance program. Rejuvenation Res. 2011, 14:45-56.
33. Haussmann M.F., Winkler D.W., O'Reilly K.M., Huntington C.E., Nisbet I.C., Vleck C.M. Telomeres shorten more slowly in long-lived birds and mammals than in short-lived ones. Proc. R. Soc. Lond. B Biol. Sci. 2003, 270:1387-1392.
34. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 1961, 25(3):585-621.
35. Hayflick L. The cell biology of human aging. N. Eng. J. Med. 1976, 295(23):1302-1308.
36. Herbig U., Ferreira M., Condel L., Carey D., Sedivy J.M. Cellular senescence in aging primates. Science 2006, 311(5765):1257.
37. Herbig U., Sedivy J.M. Regulation of growth arrest in senescence: telomere damage is not the end of the story. Mech. Ageing Dev. 2006, 127:16-24.
38. Jacobs T.L., Epel E.S., Lin J., Blackburn E.H., Wolkowitz O.M., Bridwell D.A., Zanesco A.P., Aichele S.R., Sahdra B.K., MacLean K.A., King B.G., Shaver P.R., Rosenberg E.L., Ferrer E., Wallace B.A., Saron C.D. Intensive meditation training, immune cell telomerase activity, and psychological mediators. Psychoneuroendocrinology 2011, 36:664-681.
39. Jeyapalan J.C., Ferreira M., Sedivy J.M., Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech. Ageing Dev. 2007, 128(1):36-44.
40. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015.
41. Lavretsky H., Epel E.S., Siddarth P., Nazarian N., Cyr N.S., Khalsa D.S., Lin J., Blackburn E., Irwin M.R. A pilot study of yogic meditation for family dementia caregivers with depressive symptoms: effects on mental health, cognition, and telomerase activity. Int. J. Geriatr. Psychiatry 2013, 28(1):57-65.
42. López-Otín C., Blasco M.A., Partridge L., Serrano M., Kroemer G. The hallmarks of aging. Cell 2013, 153(6):1194-1217.
43. Mason P.J., Wilson D.B., Bessler M. Dyskeratosis congenita - a disease of dysfunctional telomere maintenance. Curr. Mol. Med. 2005, 5(2):59-170.
44. Masutomi K., Yu E.Y., Khurts S., Ben-Porath I., Currier J.L., Metz G.B., Brooks M.W., Kaneko S., Murakami S., DeCaprio J.A., Weinberg R.A., Stewart S.A., Hahn W.C. Telomerase maintains telomere structure in normal human cells. Cell 2003, 114:241-253.
45. Mather K.A., Jorm A.F., Parslow R.A., Christensen H. Is telomere length a biomarker of aging? A review. J. Gerontol. A Biol. Sci. Med. Sci. 2011, 66(2):202-213.
46. Ornish D., Lin J., Daubenmier J., Weidner G., Epel E., Kemp C., Magbanua M.J., Marlin R., Yglecias L., Carroll P.R., Blackburn E.H. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol. 2008, 9:1048-1057.
47. Sanders J.L., Newman A.B. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither?. Epidemiol. Rev. 2013, Epub ahead of print.
48. Sfeir A.J., Chai W., Shay J.W., Wright W.E. Telomere end processing: the terminal nucleotides of human chromosomes. Mol. Cell. 2005, 18:131-138.
49. Hay J.W., Bacchetti S. A survey of telomerase activity in human cancer. Eur. J. Cancer 1997, 33:787-791.
50. Slagboom P.E., Droog S., Boomsma D.I. Genetic determination of telomere size in humans: a twin study of three age groups. Am. J. Human Genet. 1994, 55:876-882.
51. Soerensen M., Thinggaard M., Nygaard M., Dato S., Tan Q., Hjelmborg J., Andersen-Ranberg K., Stevnsner T., Bohr V.A., Kimura M., Aviv A., Christensen K., Christiansen L. Genetic variation in TERT and TERC and human leukocyte telomere length and longevity: a cross-sectional and longitudinal analysis. Aging Cell 2012, 11(2):223-227.
52. Stewart S.A., Ben-Porath I., Carey V.J., O'Connor B.F., Hahn W.C., Weinberg R.A. Erosion of the telomeric single-strand overhang at replicative senescence. Nat. Genet. 2003, 33:492-496.
53. Strong M.A., Vidal-Cardenas S.L., Karim B., Yu H., Guo N., Greider C.W. Phenotypes in mTERT+/S and mTERTS/S mice are due to short telomeres, not telomere-independent functions oftelomerase reverse transcriptase. Mol. Cell Biol. 2011, 31:2369-2379.
54. Tichon A., Eitan E., Kurkalli B.G., Braiman A., Gazit A., Slavin S., Beith-Yannai E., Priel E. Oxidative stress protection by novel telomerase activators in mesenchymal stem cells derived from healthy and diseased individuals. Curr. Mol. Med. 2013, 13(6):1010-1022.
55. Tomas-Loba A., Flores I., Fernandez-Marcos P.J., Cayuela M.L., Maraver A., Tejera A., Borras C., Matheu A., Klatt P., Flores J.M., Viña J., Serrano M., Blasco M.A. Telomerase reverse transcriptase delays aging in cancer resistant mice. Cell 2008, 135:609-622.
56. Vera E., Bernardes de Jesus B., Foronda M., Flores J.M., Blasco M.A. The rate of increase of short telomeres predicts longevity in mammals. Cell Rep. 2012, 2(4):732-737.
57. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 2002, 27:339-344.
58. von Zglinicki T., Martin-Ruiz C.M. Telomeres as biomarkers for ageing and age-related diseases. Curr. Mol. Med. 2005, 5(2):197-203.
59. Vulliamy T., Marrone A., Goldman F., Dearlove A., Bessler M., Mason P.J., Dokal I. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001, 413:432-435.
60. Wright W.E., Shay J.W. Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat. Med. 2000, 6:849-851.
61. Wright W.E., Piatyszek M.A., Rainey W.E., Byrd W., Shay J.W. Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 1996, 18:173-179.
62. Wyllie F.S., Jones C.J., Skinner J.W., Haughton M.F., Wallis C., Wynford-Thomas D., Faragher R.G., Kipling D. Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat. Genet. 2000, 24:16-17.
63. Yamaguchi H., Calado R.T., Ly H., Kajigaya S., Baerlocher G.M., Chanock S.J., Lansdorp P.M., Young N.S. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N. Engl. J. Med. 2005, 352:1413-1424.